On Monday, the Food and Drug Administration granted full approval for Pfizer/BioNTech’s Covid-19 vaccine, now marketed under the name Comirnaty, for everyone age 16 and up.“This is a pivotal ...

PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.

Pfizer PFE has committed significant resources for the development of treatments in the fields of oncology, internal medicine, immunology, inflammation and vaccines. Over the past decade, Pfizer has ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

For its approved uses, the drug accounted for $437 million in revenue for the nine months ended Sept. 30, 2024, a 26% increase compared to the same period in the prior year, according to Pfizer ...

On Monday morning, the Food and Drug Administration (FDA) granted full approval to the first Covid-19 vaccine — a significant milestone in the ongoing fight to end the pandemic.

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old biotech — if it can beat out stiff competition from the likes of ...

Pfizer has also sought regulatory approvals for the drug in Australia, India and the UK, among others. Leerink Partners in October estimated the drug's 2030 sales at $2.2 billion.

After the U.S. Food and Drug Administration gave its official stamp of approval to the Pfizer-BioNTech COVID-19 shot, some social media users tried to dismiss it by pointing to other products the ...

Full US Food and Drug Administration approval of the Pfizer/BioNTech Covid-19 vaccine is “imminent,” a senior federal official told CNN on Friday – but said no date has been mentioned.

Approval for Pfizer's two-dose vaccine was originally scheduled for Labor Day but was moved up due to a ... “We expect the Food and Drug Administration to approve one or more COVID-19 vaccines ...

Pfizer-BioNTech is seeking the Food and Drug Administration's approval for its COVID-19 vaccine, with the goal of getting the agency's green light "in the coming months." ...